GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China · Delayed Price · Currency is CNY 16.70
-0.06 (-0.36%)
May 6, 2026, 3:00 PM CST
SHA:600771 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 66.84 | 63.69 | 74.45 | 90.08 | -250.02 | -316.24 |
Depreciation & Amortization | 47.95 | 47.95 | 50.38 | 46.01 | 39.25 | 38.39 |
Other Amortization | 0.63 | 0.63 | 3.77 | 2.55 | 3.12 | 3.14 |
Loss (Gain) From Sale of Assets | - | - | 0.02 | -0.2 | 0.02 | -0.4 |
Asset Writedown & Restructuring Costs | 24.9 | 24.9 | 4.71 | 0.02 | 19.89 | 0.03 |
Loss (Gain) From Sale of Investments | 2.26 | 2.26 | 7.73 | -1.45 | 0.92 | 4.22 |
Provision & Write-off of Bad Debts | - | - | 69.36 | 24.76 | 22.2 | -26.03 |
Other Operating Activities | -22.81 | 2.43 | 23.69 | 23.08 | 51.84 | 8.14 |
Change in Accounts Receivable | -82.05 | -82.05 | 289.01 | 221.08 | 352.25 | 228.78 |
Change in Inventory | 10.98 | 10.98 | -204.87 | -157.6 | -59.63 | 9.76 |
Change in Accounts Payable | 126.45 | 126.45 | -190.49 | -25.66 | 86.1 | 155.62 |
Operating Cash Flow | 175.81 | 197.89 | 112.39 | 215.5 | 253.43 | 81.37 |
Operating Cash Flow Growth | 50.02% | 76.07% | -47.85% | -14.96% | 211.45% | - |
Capital Expenditures | -6.03 | -6.24 | -8.78 | -2.51 | -8.67 | -18.19 |
Sale of Property, Plant & Equipment | - | - | 0.04 | 0.23 | 0.03 | 0 |
Investment in Securities | 9.84 | -0.14 | 1.56 | 0.35 | 0.2 | -0.55 |
Other Investing Activities | -60.18 | -10.17 | - | 0.74 | 1.02 | 0.86 |
Investing Cash Flow | -56.36 | -16.55 | -7.17 | -1.19 | -7.41 | -17.89 |
Short-Term Debt Issued | - | - | 11.77 | - | 51.62 | 206.5 |
Long-Term Debt Issued | - | - | - | 56 | 355 | 301.86 |
Total Debt Issued | - | - | 11.77 | 56 | 406.62 | 508.36 |
Short-Term Debt Repaid | - | - | - | - | -229.5 | -288.22 |
Long-Term Debt Repaid | - | -8.14 | -254.37 | -242.98 | -260.32 | -309.8 |
Total Debt Repaid | -8.14 | -8.14 | -254.37 | -242.98 | -489.82 | -598.02 |
Net Debt Issued (Repaid) | -8.14 | -8.14 | -242.61 | -186.98 | -83.19 | -89.67 |
Common Dividends Paid | -1.19 | -1.19 | -3.95 | -14.33 | -19.8 | -18.31 |
Other Financing Activities | 19.81 | 9.33 | -0.23 | - | - | - |
Financing Cash Flow | 10.47 | 0 | -246.78 | -201.31 | -102.99 | -107.98 |
Net Cash Flow | 129.92 | 181.34 | -141.56 | 13 | 143.03 | -44.5 |
Free Cash Flow | 169.78 | 191.65 | 103.61 | 212.99 | 244.76 | 63.17 |
Free Cash Flow Growth | 57.81% | 84.97% | -51.35% | -12.98% | 287.44% | - |
Free Cash Flow Margin | 11.79% | 14.00% | 8.48% | 16.59% | 21.65% | 7.40% |
Free Cash Flow Per Share | 0.35 | 0.40 | 0.21 | 0.43 | 0.50 | 0.13 |
Cash Income Tax Paid | 203.16 | 185.38 | 144.12 | 142.15 | 111.09 | 126.71 |
Levered Free Cash Flow | 217.29 | 202.83 | 84.26 | 164.65 | 553.83 | -124.2 |
Unlevered Free Cash Flow | 217.29 | 202.83 | 88.28 | 175.23 | 566.93 | -112.27 |
Change in Working Capital | 56.04 | 56.04 | -121.72 | 30.64 | 366.21 | 370.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.